Literature DB >> 32286246

COVID-19 infections are also affected by human ACE1 D/I polymorphism.

Joris R Delanghe1, Marijn M Speeckaert2, Marc L De Buyzere2.   

Abstract

Entities:  

Keywords:  COVID-19; angiotensin-converting enzyme; plasma proteins; polymorphism

Mesh：

Substances：

Year:  2020        PMID： 32286246     DOI： 10.1515/cclm-2020-0425

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  38 in total

1.  Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A single-center cohort study.

Authors:  Serdal Baştuğ; Büşranur Çavdarlı; Aliye Baştuğ; İrfan Şencan; Ebru Tunçez; Esra Yakışık Çakır; Nizamettin Kemirtlek; Cihad Sakar; Deniz Erdem; Gülay Güleç Ceylan; Işıl Özkoçak Turan; Sümeyye Kazancıoğlu; Hürrem Bodur
Journal:  Anatol J Cardiol       Date:  2022-02       Impact factor: 1.596

Review 2.  Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression.

Authors:  J A Hubacek
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

3.  Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis.

Authors:  Cristine Dieter; Letícia de Almeida Brondani; Cristiane Bauermann Leitão; Fernando Gerchman; Natália Emerim Lemos; Daisy Crispim
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

4.  Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease.

Authors:  Mojtaba Najafi; Mohammad Reza Mahdavi
Journal:  Mol Genet Genomics       Date:  2022-10-18       Impact factor: 2.980

5.  Association of polymorphisms in genes encoding prothrombotic and cardiovascular risk factors with disease severity in COVID-19 patients: A pilot study.

Authors:  Ivana Lapić; Margareta Radić Antolic; Ivana Horvat; Vedran Premužić; Jozefina Palić; Dunja Rogić; Renata Zadro
Journal:  J Med Virol       Date:  2022-04-21       Impact factor: 20.693

Review 6.  Are we equal in adversity? Does Covid-19 affect women and men differently?

Authors:  Serge Rozenberg; Jean Vandromme; Charlotte Martin
Journal:  Maturitas       Date:  2020-05-15       Impact factor: 4.342

7.  Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.

Authors:  Juan Gómez; Guillermo M Albaiceta; Marta García-Clemente; Carlos López-Larrea; Laura Amado-Rodríguez; Inés Lopez-Alonso; Tamara Hermida; Ana I Enriquez; Pablo Herrero; Santiago Melón; Marta E Alvarez-Argüelles; José A Boga; Susana Rojo-Alba; Elías Cuesta-Llavona; Victoria Alvarez; Rebeca Lorca; Eliecer Coto
Journal:  Gene       Date:  2020-08-31       Impact factor: 3.688

Review 8.  Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review).

Authors:  Sergej Nadalin; Hrvoje Jakovac; Vjekoslav Peitl; Dalibor Karlović; Alena Buretić-Tomljanović
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

9.  ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe.

Authors:  Smiljana Ristić; Sanja Dević Pavlić; Sergej Nadalin; Nada Starčević Čizmarević
Journal:  J Infect       Date:  2021-06-16       Impact factor: 38.637

10.  Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.

Authors:  Ikram Omar Osman; Cléa Melenotte; Philippe Brouqui; Matthieu Million; Jean-Christophe Lagier; Philippe Parola; Andréas Stein; Bernard La Scola; Line Meddeb; Jean-Louis Mege; Didier Raoult; Christian A Devaux
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.